Jama

• 

  Publication Venue For

  • Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke..  323:2170-2184. 2020
  • Can a Structured, Electronic Approach to Shared Decision-making Increase Attempted Trial of Labor?.  323:2145-2146. 2020
  • Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?.  323:2024-2026. 2020
  • Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. 2020
  • Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. 2020
  • Health Outcomes With Vitamin D Supplementation-Reply..  323:1619. 2020
  • Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016..  323:1314-1316. 2020
  • Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI..  323:787-789. 2020
  • Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial..  323:527-537. 2020
  • Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials..  323:432-443. 2020
  • Dysphagia in a 34-Year-Old Woman. 2020
  • Using Propensity Score Methods to Create Target Populations in Observational Clinical Research. 2020
  • Does This Patient Have Hip Osteoarthritis?: The Rational Clinical Examination Systematic Review..  322:2323-2333. 2019
  • Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial..  322:2179-2190. 2019
  • Hiding in Plain Sight..  322:2173-2174. 2019
  • Clarifying the Meaning of Clinically Meaningful Benefit in Clinical Research: Noticeable Change vs Valuable Change. 2019
  • Machine Learning, Predictive Analytics, and Clinical Practice: Can the Past Inform the Present? 2019
  • Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. 2019
  • Development of Risk Prediction Equations for Incident Chronic Kidney Disease. 2019
  • Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials. 2019
  • Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry..  322:1682-1691. 2019
  • Antihypertensive Medication Use in Older Adults at Risk for Hip Fracture-Reply..  322:1609. 2019
  • Pain Management With Opioids in 2019-2020..  1-3. 2019
  • A Measured Dose of Optimism for the Evolution of ICU-Based Palliative Care. 2019
  • Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply..  322:1106. 2019
  • Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial..  322:1066-1076. 2019
  • Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial..  322:1054-1065. 2019
  • Improving Access to Kidney Transplantation: Business as Usual or New Ways of Doing Business?.  322:931-933. 2019
  • Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction..  1-11. 2019
  • Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial..  322:746-755. 2019
  • Time Horizons in Cost Analyses-Reply..  322:582-583. 2019
  • Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial..  322:315-325. 2019
  • Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice..  322:252-263. 2019
  • Clarification of Reporting of Potential Conflicts of Interest in JAMA Articles. 2019
  • Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial..  322:123-133. 2019
  • Did This Patient Have Cardiac Syncope?: The Rational Clinical Examination Systematic Review..  321:2448-2457. 2019
  • Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke..  321:2306-2315. 2019
  • Hip Fractures in Older Adults in 2019..  321:2231-2232. 2019
  • Medication-Based Treatment to Address Opioid Use Disorder..  321:2071-2072. 2019
  • Using Instrumental Variables to Address Bias From Unobserved Confounders..  321:2124-2125. 2019
  • Counteracting Health Misinformation: A Role for Medical Journals?.  321:1863-1864. 2019
  • Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial..  321:1880-1894. 2019
  • Fever, Rash, and Migratory Polyarthralgias..  321:1930-1931. 2019
  • Management of Hepatitis C in 2019. 2019
  • Management of Preexisting Diabetes in Pregnancy: A Review..  321:1811-1819. 2019
  • Evaluation for Fibrosis After Cure of Hepatitis C-Reply..  321:1535. 2019
  • Overview of Cost-effectiveness Analysis..  321:1400-1401. 2019
  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial..  321:1261-1274. 2019
  • Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial..  321:1275-1285. 2019
  • Hypertension in Young Adults and Subsequent Cardiovascular Disease-Reply..  321:1310-1311. 2019
  • Marginal Effects-Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models..  321:1304-1305. 2019
  • Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial..  321:1176-1186. 2019
  • Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality..  321:1081-1095. 2019
  • Choosing a Time Horizon in Cost and Cost-effectiveness Analyses..  321:1096-1097. 2019
  • Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018..  321:1069-1080. 2019
  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference..  321:983-997. 2019
  • A New Personalized, Patient-Centric, and Cost-Conscious Guideline for Contemporary Cholesterol Management..  321:749-750. 2019
  • Addressing the Psychological Symptoms of Critical Illness: The Importance of "Negative" Trials in Guiding Next Steps..  321:649-650. 2019
  • Will This Patient Be Difficult to Intubate?: The Rational Clinical Examination Systematic Review..  321:493-503. 2019
  • The Evolving Story of Triglycerides and Coronary Heart Disease Risk..  321:347-349. 2019
  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial..  321:69-79. 2019
  • Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial..  321:44-55. 2019
  • Providing Individual Research Results to Participants-Reply..  320:2601. 2018
  • Vitamin D Receptor Agonists for Patients Undergoing Hemodialysis..  320:2319-2321. 2018
  • Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement..  320:2231-2241. 2018
  • Maryland's Hospital Global Budget Program-Reply..  320:2040-2041. 2018
  • Odds Ratios vs Risk Ratios-Reply..  320:2041-2042. 2018
  • Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis..  320:2031-2032. 2018
  • Injection Drug Use-Associated Infective Endocarditis-Reply..  320:1939-1940. 2018
  • Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life..  320:1774-1782. 2018
  • Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial..  320:1764-1773. 2018
  • Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial..  320:1649-1658. 2018
  • Presence of High-Intensity Sweeteners in Popular Cigarillos of Varying Flavor Profiles..  320:1380-1383. 2018
  • Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial..  320:1249-1258. 2018
  • Esophageal High-Resolution Manometry in Gastroesophageal Reflux Disease..  320:1279-1280. 2018
  • On Deep Learning for Medical Image Analysis..  320:1192-1193. 2018
  • Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial..  320:880-891. 2018
  • Return of Research Results to Study Participants: Uncharted and Untested..  320:435-436. 2018
  • Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment..  320:433-434. 2018
  • Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial..  320:245-254. 2018
  • Evaluating Health Technology Through Pragmatic Trials: Novel Approaches to Generate High-Quality Evidence..  320:137-138. 2018
  • Screening for Atrial Fibrillation With a Wearable Device..  320:139-141. 2018
  • Endocarditis..  320:102. 2018
  • Management Considerations in Infective Endocarditis: A Review..  320:72-83. 2018
  • Odds Ratios-Current Best Practice and Use..  320:84-85. 2018
  • Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?.  320:38-39. 2018
  • Supporting the Next Generation of Biomedical Researchers..  320:29-30. 2018
  • Anesthesia Care Handovers and Risk of Adverse Outcomes..  319:2235-2236. 2018
  • Ticagrelor Following Coronary Artery Bypass Grafting: For Better Vein Graft Patency or Better Patient Outcomes?.  319:1661-1662. 2018
  • Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis..  319:1566-1579. 2018
  • Challenges in Interpreting the Lipid-Lowering Trials: Biology vs Ecology..  319:1549-1551. 2018
  • Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial..  319:1554-1565. 2018
  • Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis..  319:1473-1484. 2018
  • Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis..  319:1485-1496. 2018
  • The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States..  319:1444-1472. 2018
  • Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial..  319:1331-1340. 2018
  • Gastroesophageal Reflux Monitoring..  319:1271-1272. 2018
  • Absolute vs Additive Net Reclassification Index..  319:616. 2018
  • Improving Evidence for Implementation of Guideline-Based Care in Low- and Middle-Income Countries..  319:554-556. 2018
  • Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality..  319:463-473. 2018
  • Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery..  319:365-374. 2018
  • Taxes and Sugar-Sweetened Beverages..  319:229-230. 2018
  • Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014..  319:49-61. 2018
  • Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes..  318:2211-2223. 2017
  • The New 2017 ACC/AHA Guidelines "Up the Pressure" on Diagnosis and Treatment of Hypertension..  318:2083-2084. 2017
  • Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review..  318:1810-1819. 2017
  • Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial..  318:1550-1560. 2017
  • Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age..  318:1367-1376. 2017
  • Perioperative Management of High-Risk Patients: Going Beyond "Avoid Hypoxia and Hypotension"..  318:1330-1332. 2017
  • Urinalysis in the Evaluation of Proliferative Glomerulonephritis..  318:1276-1277. 2017
  • Genetic Studies Help Clarify the Complexities of Lipid Biology and Treatment..  318:915-917. 2017
  • Guideline Recommendations for Statin Therapy-Reply..  318:964. 2017
  • Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial..  318:713-720. 2017
  • PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability..  318:711-712. 2017
  • Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial..  318:536-547. 2017
  • Childhood Pneumonia..  318:490. 2017
  • Does This Child Have Pneumonia?: The Rational Clinical Examination Systematic Review..  318:462-471. 2017
  • Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial..  318:57-67. 2017
  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial..  317:2392-2401. 2017
  • Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial..  317:1958-1966. 2017
  • Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines..  317:1563-1567. 2017
  • The DASH Diet, 20 Years Later..  317:1529-1530. 2017
  • Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative..  317:1461-1470. 2017
  • Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer..  317:1141-1150. 2017
  • Adverse Effects of Statins..  317:1079. 2017
  • Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation..  317:1057-1067. 2017
  • OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply..  317:535-536. 2017
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China..  317:280-289. 2017
  • Wearable Technology and Long-term Weight Loss..  317:318. 2017
  • Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial..  317:156-164. 2017
  • Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials..  317:146-155. 2017
  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015..  317:165-182. 2017
  • Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic..  317:139-141. 2017
  • Updated Recommendations for Cost-effectiveness Studies-Reply..  317:90. 2017
  • Reducing Bias in Academic Search Committees..  316:2595-2596. 2016
  • Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial..  316:2094-2103. 2016
  • Reducing Adverse Drug Events: The Need to Rethink Outpatient Prescribing..  316:2092-2093. 2016
  • Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage..  316:2025-2035. 2016
  • Evolving Approaches for Statins in Primary Prevention: Progress, but Questions Remain..  316:1981-1983. 2016
  • Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence..  316:2041-2043. 2016
  • Health Care Reform in the United States..  316:1923-1924. 2016
  • Mechanisms of Ascites Development-Reply..  316:1829. 2016
  • Mental Illness, Release From Prison, and Social Context..  316:1771-1772. 2016
  • Realizing the Full Potential of Precision Medicine in Health and Health Care..  316:1659-1660. 2016
  • Association Between Therapeutic Hypothermia and Survival After In-Hospital Cardiac Arrest..  316:1375-1382. 2016
  • OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial..  316:1366-1374. 2016
  • Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine..  316:1093-1103. 2016
  • Priorities for Improving Hearing Health Care for Adults: A Report From the National Academies of Sciences, Engineering, and Medicine..  316:819-820. 2016
  • Vital Directions for Health and Health Care: An Initiative of the National Academy of Medicine..  316:711-712. 2016
  • Open Access Platforms for Sharing Clinical Trial Data--Reply..  316:666-667. 2016
  • Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy..  316:661-663. 2016
  • Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial..  316:500-508. 2016
  • Evaluation of New-Onset Ascites..  316:340-341. 2016
  • Better Palliative Care for All: Improving the Lived Experience With Cancer..  316:29-30. 2016
  • Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial..  316:40-50. 2016
  • Effect of Palliative Care-Led Meetings for Families of Patients With Chronic Critical Illness: A Randomized Clinical Trial..  316:51-62. 2016
  • Diet and Exercise for Obese Patients With Heart Failure--Reply..  315:2619-2620. 2016
  • Roles of Academic and Public Health Systems in Advancing Population Health--Reply..  315:2623-2624. 2016
  • Implementing MACRA: Implications for Physicians and for Physician Leadership..  315:2397-2398. 2016
  • Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial..  315:2178-2189. 2016
  • Persistent Rash in a Patient Receiving Total Parenteral Nutrition..  315:2223-2224. 2016
  • Firearm Access and Risk of Suicide--Reply..  315:2124-2125. 2016
  • Lyme Disease Serology..  315:1780-1781. 2016
  • Moving From Clinical Trials to Precision Medicine: The Role for Predictive Modeling..  315:1713-1714. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial..  315:1580-1590. 2016
  • Breast Cancer Screening: Benefit or Harm?--Reply..  315:1402-1403. 2016
  • Clinical Breast Examination and Breast Cancer Screening Guideline--Reply..  315:1404. 2016
  • Use of Open Access Platforms for Clinical Trial Data..  315:1283-1284. 2016
  • Visual Acuity Screening Among Asymptomatic Older Adults..  315:875-876. 2016
  • Value of Personalized Medicine..  315:613. 2016
  • Academic Health Systems' Third Curve: Population Health Improvement..  315:459-460. 2016
  • Why Physicians Should Oppose Assisted Suicide..  315:247-248. 2016
  • Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial..  315:36-46. 2016
  • Repeated In Vitro Fertilization Cycles for Infertility..  314:2627-2629. 2015
  • Alternating Electric Fields for the Treatment of Glioblastoma..  314:2511-2513. 2015
  • Initial Interventions for Out-of-Hospital Cardiac Arrest--Reply..  314:2414. 2015
  • Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial..  314:2251-2262. 2015
  • Getting Serious About Reducing Suicide: More "How" and Less "Why"..  314:2229-2230. 2015
  • Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality..  314:2263-2270. 2015
  • Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial..  314:2137-2146. 2015
  • The National Academy of Medicine's Vision: Leadership, Innovation, and Impact for a Healthier Future..  314:2127-2128. 2015
  • Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention..  314:2045-2053. 2015
  • Advancing Cardiovascular Science..  314:1924-1925. 2015
  • Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure..  314:1973-1975. 2015
  • Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review..  314:1955-1965. 2015
  • Risk Prediction for Individuals--Reply..  314:1875-1876. 2015
  • Use of Implantable Cardioverter-Defibrillators Among Medicare Patients--Reply..  314:1874-1875. 2015
  • Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial..  314:1720-1730. 2015
  • Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks..  314:1691-1692. 2015
  • Benefits and Harms of Breast Cancer Screening: A Systematic Review..  314:1615-1634. 2015
  • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society..  314:1599-1614. 2015
  • Can Mobile Health Applications Facilitate Meaningful Behavior Change?: Time for Answers..  314:1236-1237. 2015
  • The Lasker Awards--Recognizing and Valuing Investments in Cardiovascular Research..  314:1121-1122. 2015
  • Evaluating Discrimination of Risk Prediction Models: The C Statistic..  314:1063-1064. 2015
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012..  314:1039-1051. 2015
  • Evaluation of Flibanserin: Science and Advocacy at the FDA..  314:869-870. 2015
  • Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial..  314:570-581. 2015
  • Does This Patient Have Posttraumatic Stress Disorder?: Rational Clinical Examination Systematic Review..  314:501-510. 2015
  • Fever and Rash in a Patient With Hepatitis..  314:400-401. 2015
  • Outlook for Alternative Payment Models in Fee-for-Service Medicare..  314:341-342. 2015
  • Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013..  314:255-264. 2015
  • The Role of Physicians in the Era of Predictive Analytics..  314:25-26. 2015
  • Broadly Neutralizing Antibodies and the Development of Vaccines..  313:2419-2420. 2015
  • Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction..  313:2433-2440. 2015
  • The Church Supper: James Baare Turnbull..  313:2408-2409. 2015
  • Cognitive aging: a report from the Institute of Medicine..  313:2121-2122. 2015
  • Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial..  313:2033-2043. 2015
  • Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis..  313:1736-1744. 2015
  • Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection..  313:1728-1735. 2015
  • Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission..  313:1513-1514. 2015
  • Long-term survival following bariatric surgery in the VA health system--reply..  313:1474-1475. 2015
  • JAMA Cardiovascular Disease Theme Issue: Call for Papers. 2015
  • Clinical outcomes at 1 year following transcatheter aortic valve replacement..  313:1019-1028. 2015
  • Treatment of late-stage syphilis--reply..  313:969-970. 2015
  • Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial..  313:584-593. 2015
  • Diagnosing endocarditis in patients with Staphylococcus aureus bacteremia--reply..  313:420-421. 2015
  • Restore the US lead in biomedical research..  313:143-144. 2015
  • Association between bariatric surgery and long-term survival..  313:62-70. 2015
  • Risk profile of clinical trial participants--reply..  313:94-95. 2015
  • Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial..  312:2629-2639. 2014
  • Exercise to combat depression..  312:2166-2167. 2014
  • Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction..  312:2019-2027. 2014
  • Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial..  312:1988-1998. 2014
  • Progress against cardiovascular disease: putting the pieces together..  312:1979-1980. 2014
  • Revascularization in stable coronary artery disease..  312:2028-2029. 2014
  • Treatment of syphilis: a systematic review..  312:1905-1917. 2014
  • Hearing and vision care for older adults: sensing a need to update Medicare policy..  312:1739-1740. 2014
  • Nonobstructive coronary artery disease and risk of myocardial infarction..  312:1754-1763. 2014
  • Relieving pain in America: insights from an Institute of Medicine committee..  312:1507-1508. 2014
  • Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial..  312:1420-1428. 2014
  • Clinical management of Staphylococcus aureus bacteremia: a review..  312:1330-1341. 2014
  • Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members..  312:1033-1048. 2014
  • Open access to clinical trials data..  312:1002-1003. 2014
  • Clinical trial participation after myocardial infarction in a national cardiovascular data registry..  312:841-843. 2014
  • Patients affected by changes to hypertension guideline--reply..  312:846-847. 2014
  • Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection..  312:353-361. 2014
  • Does this adult patient have early HIV infection?: The Rational Clinical Examination systematic review..  312:278-285. 2014
  • Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review..  312:78-84. 2014
  • JAMA Theme Issue in Cardiovascular Disease: Call for Papers. 2014
  • Influence of chronic kidney disease on warfarin therapy for atrial fibrillation..  311:2541-2542. 2014
  • Ethics and regulatory complexities for pragmatic clinical trials..  311:2381-2382. 2014
  • Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%..  311:2209-2215. 2014
  • Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial..  311:1978-1987. 2014
  • Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis..  311:1889-1900. 2014
  • The pathophysiology and treatment of glaucoma: a review..  311:1901-1911. 2014
  • Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial..  311:1742-1749. 2014
  • Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial..  311:1760-1769. 2014
  • Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial..  311:2083-2091. 2014
  • Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity..  311:2063-2064. 2014
  • Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative..  311:1632-1640. 2014
  • Strategies to overcome medication nonadherence--reply..  311:1693-1694. 2014
  • Dual antiplatelet therapy after stent implantation..  311:1446. 2014
  • Proportion of US adults potentially affected by the 2014 hypertension guideline..  311:1424-1429. 2014
  • The imperative of overcoming barriers to the conduct of large, simple trials..  311:1397-1398. 2014
  • Glycated hemoglobin measurement and prediction of cardiovascular disease..  311:1225-1233. 2014
  • Clinical interpretation and implications of whole-genome sequencing..  311:1035-1045. 2014
  • Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial..  311:1023-1034. 2014
  • Underrepresentation of older adults in cancer trials--reply..  311:966-967. 2014
  • Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention..  311:836-843. 2014
  • 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)..  311:507-520. 2014
  • Recommendations for treating hypertension: what are the right goals and purposes?.  311:474-476. 2014
  • Randomized clinical trial progress to inform care for out-of-hospital cardiac arrest..  311:31-32. 2014
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial..  311:62-73. 2014
  • Adherence to diets for weight loss..  310:2676. 2013
  • Ingredients of successful interventions to improve medication adherence..  310:2611-2612. 2013
  • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial..  310:2533-2543. 2013
  • Weight loss treatment in obese adults..  310:2568. 2013
  • Outcomes of donor oocyte cycles in assisted reproduction..  310:2403-2404. 2013
  • Embedding cardiovascular research into practice..  310:2037-2038. 2013
  • Outcomes following transcatheter aortic valve replacement in the United States..  310:2069-2077. 2013
  • The cardiovascular disease researcher..  310:2048-2049. 2013
  • Improving the quality of cancer care in an aging population: recommendations from an IOM report..  310:1795-1796. 2013
  • Data and safety monitoring boards: academic credit where credit is due?.  310:1563-1564. 2013
  • Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial..  310:1571-1580. 2013
  • Nonadherence to medications..  310:1505. 2013
  • Therapy for mental stress-induced myocardial ischemia--reply..  310:1401-1402. 2013
  • Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010..  310:1284-1286. 2013
  • Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture..  310:1256-1262. 2013
  • Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial..  310:1145-1155. 2013
  • Financial incentives in primary care practice: the struggle to achieve population health goals..  310:1031-1032. 2013
  • Does this patient with shoulder pain have rotator cuff disease?: The Rational Clinical Examination systematic review..  310:837-847. 2013
  • Cost-effectiveness of bariatric surgery..  310:742-743. 2013
  • Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review..  310:731-741. 2013
  • QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy..  310:617-626. 2013
  • Therapy for chemotherapy-induced peripheral neuropathy--in reply..  310:538. 2013
  • Chelation therapy and cardiovascular outcomes--in reply..  310:431-432. 2013
  • Generic clopidogrel: time to substitute?.  310:145-146. 2013
  • Myocardial thinning in patients with coronary artery disease--reply..  310:207-208. 2013
  • Preventing heart failure..  310:44-45. 2013
  • Incidence rate of breast cancer in young women..  309:2433-2434. 2013
  • Incidence rate of breast cancer in young women..  309:2434-2435. 2013
  • Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke..  309:2480-2488. 2013
  • Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial..  309:2139-2149. 2013
  • Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review..  309:2035-2042. 2013
  • Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse..  309:2016-2024. 2013
  • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial..  309:2005-2015. 2013
  • Does this woman have an ectopic pregnancy?: the rational clinical examination systematic review..  309:1722-1729. 2013
  • Relationship between occurrence of surgical complications and hospital finances..  309:1599-1606. 2013
  • Realizing the opportunities of genomics in health care..  309:1463-1464. 2013
  • Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial..  309:1368-1378. 2013
  • Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial..  309:1359-1367. 2013
  • Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial..  309:1241-1250. 2013
  • Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial..  309:1268-1277. 2013
  • Mental illness and new gun law reforms: the promise and peril of crisis-driven policy..  309:1233-1234. 2013
  • Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial..  309:1125-1135. 2013
  • Professionalism in graduate medical education..  309:1110-1111. 2013
  • Association between bleeding events and in-hospital mortality after percutaneous coronary intervention..  309:1022-1029. 2013
  • Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes..  309:1014-1021. 2013
  • Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease..  309:909-918. 2013
  • Statistical analysis plans in observational research--reply..  309:32. 2013
  • Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials..  309:55-62. 2013
  • Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction..  308:2097-2107. 2012
  • Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative..  308:2093-2094. 2012
  • Weight and mortality in adults with diabetes..  308:2079-2080. 2012
  • Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes..  308:1898-1905. 2012
  • Physical activity to combat depression in chronic heart failure..  308:1738. 2012
  • The cover: Ritratto del Cuore (portrait of the heart)..  308:1718-1719. 2012
  • The future of cardiovascular clinical research: informatics, clinical investigators, and community engagement..  308:1747-1748. 2012
  • Viewing cardiovascular research through the eyes of past, present, and future generations..  308:1809-1810. 2012
  • Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy..  1-10. 2012
  • Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial..  308:1357-1365. 2012
  • β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease..  308:1340-1349. 2012
  • Detecting obstructive coronary disease with CT angiography and noninvasive fractional flow reserve..  308:1269-1270. 2012
  • Diagnostic accuracy of fractional flow reserve from anatomic CT angiography..  308:1237-1245. 2012
  • Health benefits of gastric bypass surgery after 6 years..  308:1122-1131. 2012
  • The value of statistical analysis plans in observational research: defining high-quality research from the start..  308:773-774. 2012
  • Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial..  308:700-709. 2012
  • Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery..  308:475-484. 2012
  • Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial..  308:465-474. 2012
  • Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity..  308:257-264. 2012
  • Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial..  308:157-164. 2012
  • Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator..  307:2600-2608. 2012
  • Clopidogrel efficacy and cigarette smoking status..  307:2495-2496. 2012
  • Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial..  307:2041-2049. 2012
  • A new look at an old therapy..  307:1972-1973. 2012
  • Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010..  307:1838-1847. 2012
  • Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices..  307:1727-1735. 2012
  • Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer..  307:1611-1620. 2012
  • Does this adult patient have a blunt intra-abdominal injury?.  307:1517-1527. 2012
  • Does this patient have a severe upper gastrointestinal bleed?.  307:1072-1079. 2012
  • Evaluation for coronary artery disease and medicare spending..  307:911. 2012
  • Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality..  307:813-822. 2012
  • Does this patient with liver disease have cirrhosis?.  307:832-842. 2012
  • A piece of my mind. A perfect match..  307:673. 2012
  • Integrating technology into health care: what will it take?.  307:569-570. 2012
  • Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587..  307:453. 2012
  • Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial..  307:265-274. 2012
  • International variation in and factors associated with hospital readmission after myocardial infarction..  307:66-74. 2012
  • Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation..  306:2348-2358. 2011
  • Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure..  306:2239-2247. 2011
  • Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease..  306:2221-2228. 2011
  • Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis..  306:2248-2254. 2011
  • Cardiology in 2011--amazing opportunities, huge challenges..  306:2158-2159. 2011
  • Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction..  306:2120-2127. 2011
  • Association between physician billing and cardiac stress testing patterns following coronary revascularization..  306:1993-2000. 2011
  • Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)..  306:1549-1556. 2011
  • Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients..  306:1461-1467. 2011
  • Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial..  306:1329-1337. 2011
  • Survival after bariatric surgery among high-risk patients..  306:1323. 2011
  • Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial..  306:1224-1232. 2011
  • Mental illness and firearm violence..  306:930-931. 2011
  • Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials..  306:711-720. 2011
  • Sensitive troponin I assay in patients with suspected acute coronary syndrome..  306:488. 2011
  • Clinically relevant changes in family history of cancer over time..  306:172-178. 2011
  • Fibrate use in the United States and Canada..  306:157. 2011
  • Appropriateness of percutaneous coronary intervention..  306:53-61. 2011
  • Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention..  305:2540-2547. 2011
  • Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis..  305:2556-2564. 2011
  • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease..  305:2432-2439. 2011
  • Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes..  305:2456-2457. 2011
  • Survival among high-risk patients after bariatric surgery..  305:2419-2426. 2011
  • Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial..  305:1863-1872. 2011
  • An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial..  305:1136-1137. 2011
  • A historical perspective on clinical trials innovation and leadership: where have the academics gone?.  305:713-714. 2011
  • Minding the gap between efforts to reduce readmissions and disparities..  305:715-716. 2011
  • Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery..  305:585-591. 2011
  • Association between stroke center hospitalization for acute ischemic stroke and mortality..  305:373-380. 2011
  • Standards for education and credentialing in critical care medicine..  305:296-297. 2011
  • Use of florbetapir-PET for imaging beta-amyloid pathology..  305:275-283. 2011
  • Non-evidence-based ICD implantations in the United States..  305:43-49. 2011
  • Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial..  304:2485-2493. 2010
  • Therapies for refractory hypoxemia in acute respiratory distress syndrome..  304:2521-2527. 2010
  • Association between familial atrial fibrillation and risk of new-onset atrial fibrillation..  304:2263-2269. 2010
  • Achieving meaningful device surveillance: from reaction to proaction..  304:2065-2066. 2010
  • Does this patient have malaria?.  304:2048-2056. 2010
  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis..  304:1821-1830. 2010
  • Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial..  304:1576-1583. 2010
  • Variation in use of blood transfusion in coronary artery bypass graft surgery..  304:1568-1575. 2010
  • Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis..  304:1350-1357. 2010
  • Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial..  304:1339-1349. 2010
  • Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality..  304:967-975. 2010
  • Does this patient have delirium?: value of bedside instruments..  304:779-786. 2010
  • Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial..  304:755-762. 2010
  • Violent behavior in mental illness: the role of substance abuse..  304:563-564. 2010
  • Can this patient read and understand written health information?.  304:76-84. 2010
  • Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention..  303:2156-2164. 2010
  • Association of family income supplements in adolescence with development of psychiatric and substance use disorders in adulthood among an American Indian population..  303:1954-1960. 2010
  • Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia..  303:1823-1831. 2010
  • Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure..  303:1716-1722. 2010
  • Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006..  303:1625-1631. 2010
  • Evidence strength in FDA premarket approval of cardiovascular devices..  303:1599-1600. 2010
  • Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction..  303:1392-1400. 2010
  • Age- and sex-specific genomic profiles in non-small cell lung cancer..  303:535-543. 2010
  • Improving health by taking it personally..  303:363-364. 2010
  • Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention..  302:2458-2464. 2009
  • Diet, exercise habits, and risk of Alzheimer disease..  302:2431. 2009
  • Intraoperative diagnosis and management of patent foramen ovale..  302:2317. 2009
  • Acute-onset floaters and flashes: is this patient at risk for retinal detachment?.  302:2243-2249. 2009
  • Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes..  302:2207-2213. 2009
  • Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome..  302:2111-2118. 2009
  • Clinical research sites--the underappreciated component of the clinical research system..  302:2025-2027. 2009
  • Use of aldosterone antagonists in heart failure..  302:1658-1665. 2009
  • Racial differences in survival after in-hospital cardiac arrest..  302:1195-1201. 2009
  • Evaluating dopamine reward pathway in ADHD: clinical implications..  302:1084-1091. 2009
  • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy..  302:849-857. 2009
  • Sex differences in mortality following acute coronary syndromes..  302:874-882. 2009
  • Heart failure performance measures and outcomes: real or illusory gains..  302:792-794. 2009
  • Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study..  302:774-780. 2009
  • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality..  302:412-423. 2009
  • Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival..  302:290-297. 2009
  • Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment..  302:92-93. 2009
  • Novel and conventional biomarkers for prediction of incident cardiovascular events in the community..  302:49-57. 2009
  • Body mass index and risk, age of onset, and survival in patients with pancreatic cancer..  301:2553-2562. 2009
  • BNP-guided heart failure therapy in older patients..  301:2091-2092. 2009
  • Tamsulosin and the intraoperative floppy iris syndrome..  301:2044-2045. 2009
  • Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial..  301:1883-1891. 2009
  • Oversimplifying primary care supply and shortages..  301:1920-1922. 2009
  • Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention..  301:1779-1789. 2009
  • Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial..  301:1451-1459. 2009
  • Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial..  301:1439-1450. 2009
  • Distributing US health aid..  301:1339-1340. 2009
  • Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome..  301:937-944. 2009
  • Scientific evidence underlying the ACC/AHA clinical practice guidelines..  301:831-841. 2009
  • Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer..  301:745-752. 2009
  • BNP-guided therapy for heart failure..  301:432-434. 2009
  • Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer..  301:404-414. 2009
  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)..  301:39-51. 2009
  • Measuring mental health in child soldiers..  300:2729. 2008
  • Disparities in liver transplantation before and after introduction of the MELD score..  300:2371-2378. 2008
  • Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries..  300:2398-2406. 2008
  • Organizational improvements to enhance modern clinical epidemiology..  300:2300-2302. 2008
  • Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives..  300:1897-1903. 2008
  • QRS duration in patients hospitalized for worsening heart failure..  300:1880. 2008
  • Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?.  300:1793-1805. 2008
  • Ethical considerations for short-term experiences by trainees in global health..  300:1456-1458. 2008
  • Prevalence of symptomatic pelvic floor disorders in US women..  300:1311-1316. 2008
  • Comparison of mental health between former child soldiers and children never conscripted by armed groups in Nepal..  300:691-702. 2008
  • Balancing disclosure of diagnosis and assent for research in children with HIV..  300:576-578. 2008
  • Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy..  300:189-196. 2008
  • Preterm birth, long-term survival, and fertility..  300:167. 2008
  • Improving hypertension control rates: technology, people, or systems?.  299:2896-2898. 2008
  • Association of family history with cancer recurrence and survival among patients with stage III colon cancer..  299:2515-2523. 2008
  • Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure..  299:2533-2542. 2008
  • Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial..  299:1914-1921. 2008
  • Next-generation drug-eluting stents: a spirited step forward or more of the same..  299:1952-1953. 2008
  • Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial..  299:1777-1787. 2008
  • The great debate of 2008--how low to go in preventive cardiology?.  299:1718-1720. 2008
  • Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer..  299:1574-1587. 2008
  • Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth..  299:1429-1436. 2008
  • Centralized biorepositories for genetic and genomic research..  299:1359-1361. 2008
  • Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial..  299:1139-1148. 2008
  • Adjuvant therapy for surgically resected pancreatic adenocarcinoma..  299:1066-1067. 2008
  • Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial..  299:1019-1026. 2008
  • Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome..  299:532-539. 2008
  • Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial..  298:2497-2506. 2007
  • Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction..  298:2371-2380. 2007
  • Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer..  298:2275-2280. 2007
  • Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials..  298:2009-2019. 2007
  • Nonfasting triglycerides and cardiovascular risk..  298:2004. 2007
  • Validity of reported genetic risk factors for acute coronary syndrome..  298:1758. 2007
  • Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure..  298:1525-1532. 2007
  • Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death..  298:1517-1524. 2007
  • Management of diabetic retinopathy: a systematic review..  298:902-916. 2007
  • Access and diversity in academic mentoring..  298:739. 2007
  • Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer..  298:754-764. 2007
  • Clinical utility of different lipid measures for prediction of coronary heart disease in men and women..  298:776-785. 2007
  • Does this child have appendicitis?.  298:438-451. 2007
  • Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy..  298:405-412. 2007
  • Changing the organization of health care..  298:286-287. 2007
  • Algorithms for assessing cardiovascular risk in women..  298:175-176. 2007
  • Childhood cancer survivors, late effects, and a new model for understanding survivorship..  297:2762-2764. 2007
  • Does this patient have dementia?.  297:2391-2404. 2007
  • Pay for performance, quality of care, and outcomes in acute myocardial infarction..  297:2373-2380. 2007
  • The enigma of drug-eluting stents: hope, hype, humility, and advancing patient care..  297:2028-2030. 2007
  • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006..  297:1892-1900. 2007
  • Pexelizumab and the APEX AMI trial..  297:1881. 2007
  • Does ranolazine have a place in the treatment of acute coronary syndromes?.  297:1823-1825. 2007
  • Effect of 10 days of bed rest on skeletal muscle in healthy older adults..  297:1772-1774. 2007
  • Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial..  297:1657-1666. 2007
  • Contemporary clinical profile and outcome of prosthetic valve endocarditis..  297:1354-1361. 2007
  • Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials..  297:1332-1343. 2007
  • One-year cardiovascular event rates in outpatients with atherothrombosis..  297:1197-1206. 2007
  • Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial..  297:820-830. 2007
  • Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial..  297:591-602. 2007
  • Economic return of clinical trials performed under the pediatric exclusivity program..  297:480-488. 2007
  • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation..  297:159-168. 2007
  • Association between performance measures and clinical outcomes for patients hospitalized with heart failure..  297:61-70. 2007
  • Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial..  297:43-51. 2007
  • Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing..  296:2968-2969. 2006
  • Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure..  296:2217-2226. 2006
  • Do opiates affect the clinical evaluation of patients with acute abdominal pain?.  296:1764-1774. 2006
  • Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence..  296:1757-1763. 2006
  • Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression..  296:1609-1618. 2006
  • Does this patient with headache have a migraine or need neuroimaging?.  296:1274-1283. 2006
  • Peer-reviewed publication of clinical trials completed for pediatric exclusivity..  296:1266-1273. 2006
  • Effect of rimonabant on weight and cardiometabolic risk factors..  296:649-650. 2006
  • Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita..  296:585-588. 2006
  • Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model..  296:412-420. 2006
  • An outbreak of Fusarium keratitis associated with contact lens wear in Singapore..  295:2867-2873. 2006
  • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study..  295:2492-2502. 2006
  • Sunitinib in patients with metastatic renal cell carcinoma..  295:2516-2524. 2006
  • Prevention of atrial fibrillation following cardiac surgery..  295:2247-2248. 2006
  • Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials..  295:2046-2056. 2006
  • Association between hospital process performance and outcomes among patients with acute coronary syndromes..  295:1912-1920. 2006
  • Effect of blinded peer review on abstract acceptance..  295:1675-1680. 2006
  • Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial..  295:1519-1530. 2006
  • Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?.  295:1579-1580. 2006
  • Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial..  295:1264-1273. 2006
  • Transition from meeting abstract to full-length journal article for randomized controlled trials..  295:1281-1287. 2006
  • Policies and practices related to the role of board certification and recertification of pediatricians in hospital privileging..  295:905-912. 2006
  • Use of board certification and recertification of pediatricians in health plan credentialing policies..  295:913-918. 2006
  • Does the clinical examination predict lower extremity peripheral arterial disease?.  295:536-546. 2006
  • International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis..  295:180-189. 2006
  • Continuing anticoagulation following venous thromboembolism..  294:3088. 2005
  • Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes..  294:3108-3116. 2005
  • Prophylaxis against postoperative atrial fibrillation: current progress and future directions..  294:3140-3142. 2005
  • Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults..  294:3117-3123. 2005
  • Endocarditis from Staphylococcus aureus..  294:2972. 2005
  • Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease..  294:2866-2871. 2005
  • High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial..  294:2594-2600. 2005
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial..  294:2446-2454. 2005
  • Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis..  294:2465-2473. 2005
  • Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure..  294:1794-1798. 2005
  • Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial..  294:1625-1633. 2005
  • Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials..  294:1664-1670. 2005
  • Optimizing the science of quality improvement..  294:369-371. 2005
  • Patient preference and validity of randomized controlled trials..  294:41. 2005
  • Patient preference and validity of randomized controlled trials..  294:41-42. 2005
  • Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults..  293:3003-3011. 2005
  • Staphylococcus aureus endocarditis: a consequence of medical progress..  293:3012-3021. 2005
  • Cost-effectiveness of ximelagatran for stroke prevention..  293:2860-2861. 2005
  • Is this patient having a stroke?.  293:2391-2402. 2005
  • Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function..  293:2238-2244. 2005
  • Drug-eluting stents in acute myocardial infarction: is science catching up with practice?.  293:2154-2156. 2005
  • Does this patient have myasthenia gravis?.  293:1906-1914. 2005
  • Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials..  293:1759-1765. 2005
  • Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes..  293:1746-1750. 2005
  • Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial..  293:1626-1634. 2005
  • Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer..  293:1073-1081. 2005
  • Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial..  293:1063-1072. 2005
  • Does this patient have influenza?.  293:987-997. 2005
  • Blood transfusion in patients with acute coronary syndrome..  293:673. 2005
  • Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation..  293:699-706. 2005
  • Simple principles of clinical trials remain powerful..  293:489-491. 2005
  • Length of stay, functional outcome, and mortality following medical rehabilitation..  293:294-295. 2005
  • Hyperglycemia, obesity, and cancer risks on the horizon..  293:235-236. 2005
  • High-dose statins in acute coronary syndromes..  293:36. 2005
  • Does this woman have osteoporosis?.  292:2890-2900. 2004
  • Adolescents with depression..  292:2577-2578. 2004
  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative..  292:2096-2104. 2004
  • Enoxaparin vs unfractionated heparin in acute coronary syndrome..  292:1952. 2004
  • Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance..  292:1717-1723. 2004
  • Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction..  292:1563-1572. 2004
  • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes..  292:1555-1562. 2004
  • Association of aspirin use and hormone receptor status with breast cancer risk..  292:1426. 2004
  • Association of aspirin use and hormone receptor status with breast cancer risk..  292:1426-1427. 2004
  • Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial..  292:1307-1316. 2004
  • Antepartum dental radiography and low birth weight..  292:1019. 2004
  • Antepartum dental radiography and low birth weight..  292:1019. 2004
  • Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial..  292:807-820. 2004
  • Virtual colonoscopy..  292:431-432. 2004
  • Atrial fibrillation and risk of postoperative complications..  292:41. 2004
  • Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview..  292:89-96. 2004
  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial..  292:45-54. 2004
  • Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial..  292:55-64. 2004
  • STUDENTJAMA. Taking a spiritual history..  291:2881. 2004
  • Using pharmacogenetics to improve drug safety and efficacy..  291:2869-2871. 2004
  • A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry..  291:2727-2733. 2004
  • Use of antibiotics and risk of cancer..  291:2700. 2004
  • Use of antibiotics and risk of cancer..  291:2699. 2004
  • Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial..  291:2319-2327. 2004
  • The debt repayment paradox for VA clinical investigators..  291:2316. 2004
  • Ethical issues in research in complementary and alternative medicine..  291:2192. 2004
  • Ethical issues in research in complementary and alternative medicine..  291:2192. 2004
  • Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial..  291:1963-1971. 2004
  • Off-pump bypass surgery--ready for the big dance?.  291:1897-1899. 2004
  • A multicenter risk index for atrial fibrillation after cardiac surgery..  291:1720-1729. 2004
  • Cost-effectiveness of screening for proteinuria..  291:1442-1443. 2004
  • The clinical researcher--an "emerging" species..  291:882-883. 2004
  • Effect of poverty on emotional symptoms in children..  291:424. 2004
  • Antibiotics and coronary heart disease..  291:302. 2004
  • Procedural volume as a marker of quality for CABG surgery..  291:195-201. 2004
  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial..  292:45-54. 2004
  • STUDENTJAMA. Taking a spiritual history..  291:2881. 2004
  • Screening for proteinuria in US adults: a cost-effectiveness analysis..  290:3101-3114. 2003
  • Does this patient have pulmonary embolism?.  290:2849-2858. 2003
  • An outbreak of Escherichia coli O157 infection following exposure to a contaminated building..  290:2709-2712. 2003
  • Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial..  290:2428-2429. 2003
  • Oxygenated water and athletic performance..  290:2408-2409. 2003
  • Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial..  290:2284-2291. 2003
  • Psychosocial risk factors for cardiovascular disease: more than one culprit at work..  290:2190-2192. 2003
  • Relationships between poverty and psychopathology: a natural experiment..  290:2023-2029. 2003
  • Treatment of depression by mental health specialists and primary care physicians..  290:1991. 2003
  • Diagnosis of nonalcoholic fatty liver disease..  290:1577. 2003
  • Does this child have acute otitis media?.  290:1633-1640. 2003
  • Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study..  290:1583-1592. 2003
  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial..  290:1459-1466. 2003
  • Medications that prolong the QT interval..  290:1025. 2003
  • Effects of exercise and weight loss on hypertension..  290:885. 2003
  • Effects of exercise and weight loss on hypertension..  290:885-886. 2003
  • Prevalence of conventional risk factors in patients with coronary heart disease..  290:898-904. 2003
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs..  290:781-789. 2003
  • Predictors of readmission for complications of coronary artery bypass graft surgery..  290:773-780. 2003
  • Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial..  290:49-56. 2003
  • Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel..  289:3283-3289. 2003
  • Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial..  289:3106-3116. 2003
  • Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis..  289:3000-3004. 2003
  • Treatment of mild depression in elderly patients.  284:2993-2994. 2000
  • Molecular epidemiology and tuberculosis control.  284:305-307. 2000
  • Nephron-sparing surgery and renal cell carcinoma..  292:1684. 2004